myPrenatal GenomeScreen (Trisomy 21, 18 and 13 + aneuploidy X, Y + large deletions and duplications + gender)

myPrenatal Genome is a non-invasive prenatal test (NIPT) designed to assess the risk of trisomies 21, 18, 13 (Down, Edwards, Patau syndromes), as well as aneuploidy of X and Y chromosomes (XXY, XYY, XXX and X monosomy). It also identifies changes in the number of copies of genetic material fragments within chromosomes, i.e., large deletions and duplications (CNVs, copy number variants) larger than 7Mb. The fetal gender is indicated. The NIPT test is based on the analysis of free fetal DNA, performing whole genome sequencing (WGS). In the cell-free DNA (cfDNA) circulating in the pregnant woman's blood, the DNA fraction from the fetus(es) placenta(s) (cffDNA) is detected. Determination of fetal gender (in the case of twin pregnancy, it is possible to determine if at least one of the fetuses has a Y chromosome, i.e., is male).

Recommendation for when to perform the test: single and twin - from 10 weeks of pregnancy.

Sample: blood.

Execution time after reaching the laboratory: 2-4 business days.